Saint Sean 4

4 · Beta Bionics, Inc. · Filed Feb 3, 2025

Form 4

Period: 2025-01-31

DirectorPresident & CEO

Transactions

Award
Employee Stock Option (right to buy)
2025-01-31+83,268→ 83,268 total
Exercise: $7.51Exp: 2032-07-31→ Common Stock (83,268 underlying)
Award
Employee Stock Option (right to buy)
2025-01-31+494,198→ 494,198 total
Exercise: $5.10Exp: 2033-09-13→ Common Stock (494,198 underlying)
Award
Employee Stock Option (right to buy)
2025-01-31+467,944→ 467,944 total
Exercise: $17.00Exp: 2035-01-28→ Common Stock (467,944 underlying)
Award
Employee Stock Option (right to buy)
2025-01-31+749,445→ 749,445 total
Exercise: $7.51Exp: 2032-07-31→ Common Stock (749,445 underlying)
Award
Employee Stock Option (right to buy)
2025-01-31+54,911→ 54,911 total
Exercise: $5.10Exp: 2033-09-13→ Common Stock (54,911 underlying)

Footnotes (6)

[F1]One-fourth of the shares subject to this option shall vest one year after August 1, 2022, and thereafter 1/36th of the shares subject to this option shall vest on each monthly anniversary thereof.
[F2]Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock.
[F3]The shares subject to this option shall vest in 12 equal monthly installments measured four years after August 1, 2022.
[F4]One-fourth of the shares subject to this option shall vest one year after August 15, 2022, and thereafter 1/36th of the shares subject to this option shall vest on each monthly anniversary thereof.
[F5]The shares subject to this option shall vest in 12 equal monthly installments measured four years after August 15, 2022.
[F6]Vesting is monthly over a 48-month period starting January 29, 2025 in equal monthly amounts.

Documents

1 file